Hatteras Venture Partners related stories
All articles and analysis
Hatteras collects over $200m across two fundsIn addition to the closing of the funds, Hatteras has promoted Dr. Ben Scruggs and Lauren Flickinger to partner.
- Boomerang View grabs $15m Series A
Arboretum Ventures and Hatteras Venture Partners led the round.
Code Biotherapeutics pulls in $75m Series ACode Biotherapeutics, a biotech firm, has raised $75 million in Series A financing.
- VC-backed CVRx rolls out IPO
Minneapolis-based CVRx Inc, a medical device firm, has raised about $126 million for its IPO after pricing its 7 million shares at $18 per share.
VC-backed Target RWE buys NoviSciTarget RWE has acquired Durham, North Carolina-based NoviSci Inc, a software analytics and services company.
- VC-backed Qpex Biopharma names chief business officer
Qpex Biopharma Inc, a developer of anti-infective therapies, has appointed Paul Westberg as chief business officer.
- Hatteras Venture Partners collects over $137.2m for sixth fund
Hatteras Venture Partners has raised over $137.2 million for its sixth fund, according to an SEC filing.
410 Medical nabs $8 mln Series ADurham, North Carolina-based 410 Medical Inc, a medical device company, has raised $8 million in Series A financing. Hatteras Venture Partners led the round with participation from other investors that included OSF Healthcare.
- Graybug Vision procures $80 mln Series C
Silicon Valley-based Graybug Vision Inc, a clinical stage pharmaceutical company, has secured $80 million in Series C financing. CBC Group led the round with participation from other investors that included Deerfield Management, OrbiMed Advisors and Hatteras Venture Partners.
- Trefoil reels in $28 mln
San Diego-based Trefoil Therapeutics, a biotech firm, has secured $28 million in financing. Bios Partners led the round with participation from other investors that included Access Biotechnology, Hatteras Venture Partners, Aju IB Investment, Correlation Ventures, ExSight Ventures and InFocus Capital Partners.